Thalidomide Suppliers & Bulk Manufacturers

Available Forms: Capsules

Available Strengths: 50 mg, 100 mg, 150 mg , 200 mg

Reference Brands: Thalomid®(US), Thalidomide Celgene(EU)

Category: Oncology Cancer Care

Thalidomide is available in Capsules and strengths such as 50 mg, 100 mg, 150 mg , 200 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Thalidomide is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Thalidomide can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: Thalidomide is an oral immunomodulatory drug (IMiD) approved in the US and EU for treating multiple myeloma and erythema nodosum leprosum (ENL). Marketed as Thalomid® in the US and Thalidomide Celgene in the EU, it is available in 50 mg, 100 mg, 150 mg, and 200 mg capsule strengths. With anti-angiogenic and anti-inflammatory properties, thalidomide is a key oncology asset in combination therapy. Due to its teratogenic risks, distribution is strictly regulated under REMS and controlled access programs. Ideal for B2B pharmaceutical companies seeking oncology portfolio expansion, licensing, or GMP-compliant API and finished formulation sourcing in global markets.